These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 19486163)

  • 41. Strain prevalence, rather than innate virulence potential, is the major factor responsible for an increase in serious group A streptococcus infections.
    Rogers S; Commons R; Danchin MH; Selvaraj G; Kelpie L; Curtis N; Robins-Browne R; Carapetis JR
    J Infect Dis; 2007 Jun; 195(11):1625-33. PubMed ID: 17471432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Study on the dissemination of the bcrABDR cluster in Enterococcus spp. reveals that the BcrAB transporter is sufficient to confer high-level bacitracin resistance.
    Matos R; Pinto VV; Ruivo M; Lopes Mde F
    Int J Antimicrob Agents; 2009 Aug; 34(2):142-7. PubMed ID: 19324527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular epidemiology and distribution of serotypes, surface proteins, and antibiotic resistance among group B streptococci in Italy.
    Gherardi G; Imperi M; Baldassarri L; Pataracchia M; Alfarone G; Recchia S; Orefici G; Dicuonzo G; Creti R
    J Clin Microbiol; 2007 Sep; 45(9):2909-16. PubMed ID: 17634303
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
    Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
    Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
    Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of genes encoding internalization-associated proteins in Streptococcus pyogenes isolates from patients with invasive diseases and asymptomatic carriers.
    Baldassarri L; Creti R; Imperi M; Recchia S; Pataracchia M; Orefici G
    J Clin Microbiol; 2007 Apr; 45(4):1284-7. PubMed ID: 17287324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Group A Streptococci from carriage and disease in Portugal: evolution of antimicrobial resistance and T antigenic types during 2000-2002.
    Pires R; Rolo D; Gama-Norton L; Morais A; Lito L; Salgado MJ; Johansson C; Möllerberg G; Henriques-Normark B; Gonçalo-Marques J; Santos-Sanches I
    Microb Drug Resist; 2005; 11(4):360-70. PubMed ID: 16359196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of erythromycin- and clindamycin-resistant Streptococcus pyogenes emm 90 strains in Hawaii.
    Chen I; Kaufisi P; Erdem G
    J Clin Microbiol; 2011 Jan; 49(1):439-41. PubMed ID: 21068284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Declining macrolide resistance in Streptococcus pyogenes in Portugal (2007-13) was accompanied by continuous clonal changes.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    J Antimicrob Chemother; 2015 Oct; 70(10):2729-33. PubMed ID: 26142474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Susceptibility of Streptococcus pyogenes isolates from pharyngeal exudates in Cordoba (Spain)].
    Gordillo RM; Lacasa MJ; Ibarra A; Rodríguez F; Casal M
    Rev Esp Quimioter; 2003 Mar; 16(1):58-60. PubMed ID: 12750758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating serotypes and antimicrobial sensitivity of Streptococcus pyogenes isolates from children in Cyprus.
    Koliou M; Ioannou Y; Efstratiou A; Hannidou N; Pieri V; Alexandrou M; Soteriades ES
    Clin Microbiol Infect; 2007 Jun; 13(6):645-7. PubMed ID: 17378928
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterisation of levofloxacin-resistant clinical isolates of Streptococcus pyogenes in Bilbao, Spain.
    Alonso R; Mateo E; Ezpeleta G; Cisterna R
    Int J Antimicrob Agents; 2007 Aug; 30(2):183-5. PubMed ID: 17543504
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Internalization-associated proteins among Streptococcus pyogenes isolated from asymptomatic carriers and children with pharyngitis.
    Musumeci R; Bue CL; Milazzo I; Nicoletti G; Serra A; Speciale A; Blandino G
    Clin Infect Dis; 2003 Jul; 37(2):173-9. PubMed ID: 12856208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterisation and clonal analysis of group A streptococci causing pharyngitis among paediatric patients in Palermo, Italy.
    Lorino G; Gherardi G; Angeletti S; De Cesaris M; Graziano N; Maringhini S; Merlino F; Di Bernardo F; Dicuonzo G
    Clin Microbiol Infect; 2006 Feb; 12(2):189-92. PubMed ID: 16441461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic and genotypic characterization of Streptococcus pyogenes isolates displaying the MLSB phenotype of macrolide resistance in Spain, 1999 to 2005.
    Pérez-Trallero E; Montes M; Orden B; Tamayo E; García-Arenzana JM; Marimón JM
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1228-33. PubMed ID: 17242142
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distribution of subclasses mefA and mefE of the mefA gene among clinical isolates of macrolide-resistant (M-phenotype) Streptococcus pneumoniae, viridans group streptococci, and Streptococcus pyogenes.
    Ardanuy C; Tubau F; Liñares J; Domínguez MA; Pallarés R; Martín R;
    Antimicrob Agents Chemother; 2005 Feb; 49(2):827-9. PubMed ID: 15673780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dissemination of emm28 erythromycin-, clindamycin- and bacitracin-resistant Streptococcus pyogenes in Spain.
    Perez-Trallero E; Garcia C; Orden B; Marimon JM; Montes M
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):123-6. PubMed ID: 14712367
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rapid decrease in the prevalence of macrolide-resistant group A streptococci due to the appearance of two epidemic clones in Cantabria (Spain).
    Oliver MA; García-Delafuente C; Cano ME; Pérez-Hernández F; Martínez-Martínez L; Albertí S
    J Antimicrob Chemother; 2007 Aug; 60(2):450-2. PubMed ID: 17540676
    [No Abstract]   [Full Text] [Related]  

  • 59. Detection of tet(M), tet(O) and tet(S) in tetracycline/minocycline-resistant Streptococcus pyogenes bacteraemia isolates.
    Hammerum AM; Nielsen HU; Agersø Y; Ekelund K; Frimodt-Moller N
    J Antimicrob Chemother; 2004 Jan; 53(1):118-9. PubMed ID: 14657081
    [No Abstract]   [Full Text] [Related]  

  • 60. Characterization of erythromycin resistance of Streptococcus pyogenes isolated from pharyngitis patients in Korea.
    Yi YH; Choi JH; Lee HK; Lee KJ; Bae SM; Yu JY; Kim KS
    Jpn J Infect Dis; 2006 Jun; 59(3):192-4. PubMed ID: 16785703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.